Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Heather A. Wakelee, Nasser K. Altorki et al.|The Lancet|2021Cited by 1.5k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerHeather A. Wakelee, Jonathan Spicer, Shugeng Gao et al.|New England Journal of Medicine|2023Cited by 1k
Integrating genomic features for non-invasive early lung cancer detectionJacob J. Chabon, Maximilian Diehn, Emily G. Hamilton et al.|Nature|2020Cited by 689
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung CancerLecia V. Sequist, D. Ross Camidge, Jean‐Charles Soria et al.|New England Journal of Medicine|2015Cited by 664
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCChristian Rolfo, David R. Gandara, Philip C. Mack et al.|Journal of Thoracic Oncology|2018Cited by 661